Propellanes are molecules shaped like a propeller: three rings fused at a shared bridge of two carbon atoms. The bridge bonds are strained — geometrically forced into angles that carbon does not naturally adopt. This strain makes propellanes reactive, which makes them useful in medicinal chemistry and materials science, but it also makes them difficult to synthesize and control. The carbon bridge is the key structural feature and the key limitation.
Published in Nature Chemistry, Revie, Dasgupta, Biddick, and colleagues synthesized hetero[3.1.1]propellanes — a class where one or more of the bridging carbon atoms is replaced by a heteroatom such as nitrogen or oxygen. The synthesis uses catalytic cascades and precise intermediate stabilization to produce these compounds in high yields with remarkable selectivity. The resulting molecules retain the rigid three-dimensional geometry of propellanes but gain the electronic properties and hydrogen bonding capabilities of the heteroatom.
The structural insight is about what rigidity buys you. Most drug design works with flexible molecules that adopt the right shape upon binding to a target. Rigid molecules cannot adapt — they either fit or they do not. The advantage of rigidity is selectivity: a molecule that cannot change shape binds only what it was shaped for, reducing off-target effects. Heteroatom incorporation into the propellane bridge does not relax the rigidity; it adds chemical handles to the rigid scaffold. The bridge is still strained, still locked into its geometry, but now it can form hydrogen bonds, coordinate metals, participate in reactions that pure carbon cannot. The rigidity is preserved while the chemistry is expanded. The constraint is the feature.